Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise

J D Tune1, K N Richmond, M W Gorman

  • 1Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, Washington 98195, USA.

Insights

Adenosine does not regulate coronary blood flow during exercise in dogs. This study found no evidence that adenosine plays a role in exercise-induced coronary hyperemia, challenging previous assumptions about local metabolic control.

Area of Science:

  • Cardiovascular Physiology
  • Exercise Physiology
  • Pharmacology

Background:

  • Coronary exercise hyperemia is the increase in blood flow to the heart muscle during physical activity.
  • Adenosine is a nucleoside that has been implicated as a potential mediator of local metabolic control of coronary blood flow.
  • Understanding the precise mechanisms regulating coronary blood flow during exercise is crucial for cardiovascular health.

Purpose of the Study:

  • To quantitatively assess the role of adenosine in mediating coronary exercise hyperemia in a canine model.
  • To investigate whether adenosine acts as a local metabolic regulator of coronary blood flow during exercise.

Main Methods:

  • Dogs were instrumented to measure cardiac hemodynamics and coronary blood flow.
  • Cardiac interstitial adenosine concentration was estimated using a mathematical model.
  • Adenosine receptor blockade was performed using 8-phenyltheophylline (8-PT) or 8-p-sulfophenyltheophylline (8-PST) during rest and graded treadmill exercise.

Main Results:

  • Exercise significantly increased myocardial oxygen consumption and coronary blood flow, but not mean aortic pressure.
  • Estimated interstitial adenosine concentration did not rise sufficiently during exercise to suggest a role in vasodilation.
  • Adenosine receptor blockade did not affect resting or exercise-induced changes in myocardial oxygen consumption or coronary blood flow.

Conclusions:

  • Adenosine is not responsible for the local metabolic control of coronary blood flow in dogs during exercise.
  • The findings challenge the hypothesis that adenosine acts as a high-gain, negative-feedback regulator of coronary blood flow during physical exertion.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...